The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Geographic Atrophy Market Research Report 2025
Synopsis
Geographic atrophy (GA) is an advanced form of age-related macular degeneration (AMD) that causes a continuous progressive degeneration of the macula. The condition is characterized by widespread atrophy of the outer retinal tissue, retinal pigment epithelium, and choriocapillaris. It typically starts in the perifoveal region and develops to the fovea over time and causing central scotomas and permanent vision loss. Various drugs and treatments are under evaluation.
The global Geographic Atrophy market was valued at US$ 1123 million in 2023 and is anticipated to reach US$ 1714 million by 2030, witnessing a CAGR of 6.3% during the forecast period 2024-2030.
According to the Global Use of Medicines 2023 released by IQVIA Institute, the global drug expenditure in 2022 was about US$1.48 trillion (excluding COVID vaccine and treatment-related expenses), and it is predicted to grow at a rate of 3%-6% in the next few years. In terms of drug expenditure, this number in China was about 166 billion dollars in 2022. It is expected that the expenditure on medicines will increase in the next few years. From the perspective of demand, the trend of population aging, the increase of residents’ wealth and the improvement of health awareness will drive the demand for medicines.
This report aims to provide a comprehensive presentation of the global market for Geographic Atrophy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Geographic Atrophy.
Report Scope
The Geographic Atrophy market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Geographic Atrophy market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Geographic Atrophy companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Apellis Pharmaceuticals
Iveric Bio
Alkeus Pharmaceuticals
Hemera Biosciences
Allegro Ophthalmics
Stealth BioTherapeutics
Gyroscope Therapeutics
Regenerative Patch Technologies
Roche
Gensight Biologics
NGM Biopharmaceuticals
AstraZeneca
Lineage Cell Therapeutics
Allergan
Segment by Type
Above 60 Years
Above 75 Years
Segment by Application
Late-stage (Phase III)
Phase II
Phase I
Pre-clinical stage
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Geographic Atrophy companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Geographic atrophy (GA) is an advanced form of age-related macular degeneration (AMD) that causes a continuous progressive degeneration of the macula. The condition is characterized by widespread atrophy of the outer retinal tissue, retinal pigment epithelium, and choriocapillaris. It typically starts in the perifoveal region and develops to the fovea over time and causing central scotomas and permanent vision loss. Various drugs and treatments are under evaluation.
The global Geographic Atrophy market was valued at US$ 1123 million in 2023 and is anticipated to reach US$ 1714 million by 2030, witnessing a CAGR of 6.3% during the forecast period 2024-2030.
According to the Global Use of Medicines 2023 released by IQVIA Institute, the global drug expenditure in 2022 was about US$1.48 trillion (excluding COVID vaccine and treatment-related expenses), and it is predicted to grow at a rate of 3%-6% in the next few years. In terms of drug expenditure, this number in China was about 166 billion dollars in 2022. It is expected that the expenditure on medicines will increase in the next few years. From the perspective of demand, the trend of population aging, the increase of residents’ wealth and the improvement of health awareness will drive the demand for medicines.
This report aims to provide a comprehensive presentation of the global market for Geographic Atrophy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Geographic Atrophy.
Report Scope
The Geographic Atrophy market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Geographic Atrophy market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Geographic Atrophy companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Apellis Pharmaceuticals
Iveric Bio
Alkeus Pharmaceuticals
Hemera Biosciences
Allegro Ophthalmics
Stealth BioTherapeutics
Gyroscope Therapeutics
Regenerative Patch Technologies
Roche
Gensight Biologics
NGM Biopharmaceuticals
AstraZeneca
Lineage Cell Therapeutics
Allergan
Segment by Type
Above 60 Years
Above 75 Years
Segment by Application
Late-stage (Phase III)
Phase II
Phase I
Pre-clinical stage
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Geographic Atrophy companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Geographic Atrophy Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Above 60 Years
1.2.3 Above 75 Years
1.3 Market by Application
1.3.1 Global Geographic Atrophy Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Late-stage (Phase III)
1.3.3 Phase II
1.3.4 Phase I
1.3.5 Pre-clinical stage
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Geographic Atrophy Market Perspective (2019-2030)
2.2 Geographic Atrophy Growth Trends by Region
2.2.1 Global Geographic Atrophy Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Geographic Atrophy Historic Market Size by Region (2019-2024)
2.2.3 Geographic Atrophy Forecasted Market Size by Region (2025-2030)
2.3 Geographic Atrophy Market Dynamics
2.3.1 Geographic Atrophy Industry Trends
2.3.2 Geographic Atrophy Market Drivers
2.3.3 Geographic Atrophy Market Challenges
2.3.4 Geographic Atrophy Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Geographic Atrophy Players by Revenue
3.1.1 Global Top Geographic Atrophy Players by Revenue (2019-2024)
3.1.2 Global Geographic Atrophy Revenue Market Share by Players (2019-2024)
3.2 Global Geographic Atrophy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Geographic Atrophy Revenue
3.4 Global Geographic Atrophy Market Concentration Ratio
3.4.1 Global Geographic Atrophy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Geographic Atrophy Revenue in 2023
3.5 Geographic Atrophy Key Players Head office and Area Served
3.6 Key Players Geographic Atrophy Product Solution and Service
3.7 Date of Enter into Geographic Atrophy Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Geographic Atrophy Breakdown Data by Type
4.1 Global Geographic Atrophy Historic Market Size by Type (2019-2024)
4.2 Global Geographic Atrophy Forecasted Market Size by Type (2025-2030)
5 Geographic Atrophy Breakdown Data by Application
5.1 Global Geographic Atrophy Historic Market Size by Application (2019-2024)
5.2 Global Geographic Atrophy Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Geographic Atrophy Market Size (2019-2030)
6.2 North America Geographic Atrophy Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Geographic Atrophy Market Size by Country (2019-2024)
6.4 North America Geographic Atrophy Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Geographic Atrophy Market Size (2019-2030)
7.2 Europe Geographic Atrophy Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Geographic Atrophy Market Size by Country (2019-2024)
7.4 Europe Geographic Atrophy Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Geographic Atrophy Market Size (2019-2030)
8.2 Asia-Pacific Geographic Atrophy Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Geographic Atrophy Market Size by Region (2019-2024)
8.4 Asia-Pacific Geographic Atrophy Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Geographic Atrophy Market Size (2019-2030)
9.2 Latin America Geographic Atrophy Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Geographic Atrophy Market Size by Country (2019-2024)
9.4 Latin America Geographic Atrophy Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Geographic Atrophy Market Size (2019-2030)
10.2 Middle East & Africa Geographic Atrophy Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Geographic Atrophy Market Size by Country (2019-2024)
10.4 Middle East & Africa Geographic Atrophy Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Apellis Pharmaceuticals
11.1.1 Apellis Pharmaceuticals Company Detail
11.1.2 Apellis Pharmaceuticals Business Overview
11.1.3 Apellis Pharmaceuticals Geographic Atrophy Introduction
11.1.4 Apellis Pharmaceuticals Revenue in Geographic Atrophy Business (2019-2024)
11.1.5 Apellis Pharmaceuticals Recent Development
11.2 Iveric Bio
11.2.1 Iveric Bio Company Detail
11.2.2 Iveric Bio Business Overview
11.2.3 Iveric Bio Geographic Atrophy Introduction
11.2.4 Iveric Bio Revenue in Geographic Atrophy Business (2019-2024)
11.2.5 Iveric Bio Recent Development
11.3 Alkeus Pharmaceuticals
11.3.1 Alkeus Pharmaceuticals Company Detail
11.3.2 Alkeus Pharmaceuticals Business Overview
11.3.3 Alkeus Pharmaceuticals Geographic Atrophy Introduction
11.3.4 Alkeus Pharmaceuticals Revenue in Geographic Atrophy Business (2019-2024)
11.3.5 Alkeus Pharmaceuticals Recent Development
11.4 Hemera Biosciences
11.4.1 Hemera Biosciences Company Detail
11.4.2 Hemera Biosciences Business Overview
11.4.3 Hemera Biosciences Geographic Atrophy Introduction
11.4.4 Hemera Biosciences Revenue in Geographic Atrophy Business (2019-2024)
11.4.5 Hemera Biosciences Recent Development
11.5 Allegro Ophthalmics
11.5.1 Allegro Ophthalmics Company Detail
11.5.2 Allegro Ophthalmics Business Overview
11.5.3 Allegro Ophthalmics Geographic Atrophy Introduction
11.5.4 Allegro Ophthalmics Revenue in Geographic Atrophy Business (2019-2024)
11.5.5 Allegro Ophthalmics Recent Development
11.6 Stealth BioTherapeutics
11.6.1 Stealth BioTherapeutics Company Detail
11.6.2 Stealth BioTherapeutics Business Overview
11.6.3 Stealth BioTherapeutics Geographic Atrophy Introduction
11.6.4 Stealth BioTherapeutics Revenue in Geographic Atrophy Business (2019-2024)
11.6.5 Stealth BioTherapeutics Recent Development
11.7 Gyroscope Therapeutics
11.7.1 Gyroscope Therapeutics Company Detail
11.7.2 Gyroscope Therapeutics Business Overview
11.7.3 Gyroscope Therapeutics Geographic Atrophy Introduction
11.7.4 Gyroscope Therapeutics Revenue in Geographic Atrophy Business (2019-2024)
11.7.5 Gyroscope Therapeutics Recent Development
11.8 Regenerative Patch Technologies
11.8.1 Regenerative Patch Technologies Company Detail
11.8.2 Regenerative Patch Technologies Business Overview
11.8.3 Regenerative Patch Technologies Geographic Atrophy Introduction
11.8.4 Regenerative Patch Technologies Revenue in Geographic Atrophy Business (2019-2024)
11.8.5 Regenerative Patch Technologies Recent Development
11.9 Roche
11.9.1 Roche Company Detail
11.9.2 Roche Business Overview
11.9.3 Roche Geographic Atrophy Introduction
11.9.4 Roche Revenue in Geographic Atrophy Business (2019-2024)
11.9.5 Roche Recent Development
11.10 Gensight Biologics
11.10.1 Gensight Biologics Company Detail
11.10.2 Gensight Biologics Business Overview
11.10.3 Gensight Biologics Geographic Atrophy Introduction
11.10.4 Gensight Biologics Revenue in Geographic Atrophy Business (2019-2024)
11.10.5 Gensight Biologics Recent Development
11.11 NGM Biopharmaceuticals
11.11.1 NGM Biopharmaceuticals Company Detail
11.11.2 NGM Biopharmaceuticals Business Overview
11.11.3 NGM Biopharmaceuticals Geographic Atrophy Introduction
11.11.4 NGM Biopharmaceuticals Revenue in Geographic Atrophy Business (2019-2024)
11.11.5 NGM Biopharmaceuticals Recent Development
11.12 AstraZeneca
11.12.1 AstraZeneca Company Detail
11.12.2 AstraZeneca Business Overview
11.12.3 AstraZeneca Geographic Atrophy Introduction
11.12.4 AstraZeneca Revenue in Geographic Atrophy Business (2019-2024)
11.12.5 AstraZeneca Recent Development
11.13 Lineage Cell Therapeutics
11.13.1 Lineage Cell Therapeutics Company Detail
11.13.2 Lineage Cell Therapeutics Business Overview
11.13.3 Lineage Cell Therapeutics Geographic Atrophy Introduction
11.13.4 Lineage Cell Therapeutics Revenue in Geographic Atrophy Business (2019-2024)
11.13.5 Lineage Cell Therapeutics Recent Development
11.14 Allergan
11.14.1 Allergan Company Detail
11.14.2 Allergan Business Overview
11.14.3 Allergan Geographic Atrophy Introduction
11.14.4 Allergan Revenue in Geographic Atrophy Business (2019-2024)
11.14.5 Allergan Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesList of Tables
Table 1. Global Geographic Atrophy Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Above 60 Years
Table 3. Key Players of Above 75 Years
Table 4. Global Geographic Atrophy Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 5. Global Geographic Atrophy Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 6. Global Geographic Atrophy Market Size by Region (2019-2024) & (US$ Million)
Table 7. Global Geographic Atrophy Market Share by Region (2019-2024)
Table 8. Global Geographic Atrophy Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 9. Global Geographic Atrophy Market Share by Region (2025-2030)
Table 10. Geographic Atrophy Market Trends
Table 11. Geographic Atrophy Market Drivers
Table 12. Geographic Atrophy Market Challenges
Table 13. Geographic Atrophy Market Restraints
Table 14. Global Geographic Atrophy Revenue by Players (2019-2024) & (US$ Million)
Table 15. Global Geographic Atrophy Market Share by Players (2019-2024)
Table 16. Global Top Geographic Atrophy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Geographic Atrophy as of 2023)
Table 17. Ranking of Global Top Geographic Atrophy Companies by Revenue (US$ Million) in 2023
Table 18. Global 5 Largest Players Market Share by Geographic Atrophy Revenue (CR5 and HHI) & (2019-2024)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Geographic Atrophy Product Solution and Service
Table 21. Date of Enter into Geographic Atrophy Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Geographic Atrophy Market Size by Type (2019-2024) & (US$ Million)
Table 24. Global Geographic Atrophy Revenue Market Share by Type (2019-2024)
Table 25. Global Geographic Atrophy Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 26. Global Geographic Atrophy Revenue Market Share by Type (2025-2030)
Table 27. Global Geographic Atrophy Market Size by Application (2019-2024) & (US$ Million)
Table 28. Global Geographic Atrophy Revenue Market Share by Application (2019-2024)
Table 29. Global Geographic Atrophy Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 30. Global Geographic Atrophy Revenue Market Share by Application (2025-2030)
Table 31. North America Geographic Atrophy Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 32. North America Geographic Atrophy Market Size by Country (2019-2024) & (US$ Million)
Table 33. North America Geographic Atrophy Market Size by Country (2025-2030) & (US$ Million)
Table 34. Europe Geographic Atrophy Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 35. Europe Geographic Atrophy Market Size by Country (2019-2024) & (US$ Million)
Table 36. Europe Geographic Atrophy Market Size by Country (2025-2030) & (US$ Million)
Table 37. Asia-Pacific Geographic Atrophy Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 38. Asia-Pacific Geographic Atrophy Market Size by Region (2019-2024) & (US$ Million)
Table 39. Asia-Pacific Geographic Atrophy Market Size by Region (2025-2030) & (US$ Million)
Table 40. Latin America Geographic Atrophy Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 41. Latin America Geographic Atrophy Market Size by Country (2019-2024) & (US$ Million)
Table 42. Latin America Geographic Atrophy Market Size by Country (2025-2030) & (US$ Million)
Table 43. Middle East & Africa Geographic Atrophy Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 44. Middle East & Africa Geographic Atrophy Market Size by Country (2019-2024) & (US$ Million)
Table 45. Middle East & Africa Geographic Atrophy Market Size by Country (2025-2030) & (US$ Million)
Table 46. Apellis Pharmaceuticals Company Detail
Table 47. Apellis Pharmaceuticals Business Overview
Table 48. Apellis Pharmaceuticals Geographic Atrophy Product
Table 49. Apellis Pharmaceuticals Revenue in Geographic Atrophy Business (2019-2024) & (US$ Million)
Table 50. Apellis Pharmaceuticals Recent Development
Table 51. Iveric Bio Company Detail
Table 52. Iveric Bio Business Overview
Table 53. Iveric Bio Geographic Atrophy Product
Table 54. Iveric Bio Revenue in Geographic Atrophy Business (2019-2024) & (US$ Million)
Table 55. Iveric Bio Recent Development
Table 56. Alkeus Pharmaceuticals Company Detail
Table 57. Alkeus Pharmaceuticals Business Overview
Table 58. Alkeus Pharmaceuticals Geographic Atrophy Product
Table 59. Alkeus Pharmaceuticals Revenue in Geographic Atrophy Business (2019-2024) & (US$ Million)
Table 60. Alkeus Pharmaceuticals Recent Development
Table 61. Hemera Biosciences Company Detail
Table 62. Hemera Biosciences Business Overview
Table 63. Hemera Biosciences Geographic Atrophy Product
Table 64. Hemera Biosciences Revenue in Geographic Atrophy Business (2019-2024) & (US$ Million)
Table 65. Hemera Biosciences Recent Development
Table 66. Allegro Ophthalmics Company Detail
Table 67. Allegro Ophthalmics Business Overview
Table 68. Allegro Ophthalmics Geographic Atrophy Product
Table 69. Allegro Ophthalmics Revenue in Geographic Atrophy Business (2019-2024) & (US$ Million)
Table 70. Allegro Ophthalmics Recent Development
Table 71. Stealth BioTherapeutics Company Detail
Table 72. Stealth BioTherapeutics Business Overview
Table 73. Stealth BioTherapeutics Geographic Atrophy Product
Table 74. Stealth BioTherapeutics Revenue in Geographic Atrophy Business (2019-2024) & (US$ Million)
Table 75. Stealth BioTherapeutics Recent Development
Table 76. Gyroscope Therapeutics Company Detail
Table 77. Gyroscope Therapeutics Business Overview
Table 78. Gyroscope Therapeutics Geographic Atrophy Product
Table 79. Gyroscope Therapeutics Revenue in Geographic Atrophy Business (2019-2024) & (US$ Million)
Table 80. Gyroscope Therapeutics Recent Development
Table 81. Regenerative Patch Technologies Company Detail
Table 82. Regenerative Patch Technologies Business Overview
Table 83. Regenerative Patch Technologies Geographic Atrophy Product
Table 84. Regenerative Patch Technologies Revenue in Geographic Atrophy Business (2019-2024) & (US$ Million)
Table 85. Regenerative Patch Technologies Recent Development
Table 86. Roche Company Detail
Table 87. Roche Business Overview
Table 88. Roche Geographic Atrophy Product
Table 89. Roche Revenue in Geographic Atrophy Business (2019-2024) & (US$ Million)
Table 90. Roche Recent Development
Table 91. Gensight Biologics Company Detail
Table 92. Gensight Biologics Business Overview
Table 93. Gensight Biologics Geographic Atrophy Product
Table 94. Gensight Biologics Revenue in Geographic Atrophy Business (2019-2024) & (US$ Million)
Table 95. Gensight Biologics Recent Development
Table 96. NGM Biopharmaceuticals Company Detail
Table 97. NGM Biopharmaceuticals Business Overview
Table 98. NGM Biopharmaceuticals Geographic Atrophy Product
Table 99. NGM Biopharmaceuticals Revenue in Geographic Atrophy Business (2019-2024) & (US$ Million)
Table 100. NGM Biopharmaceuticals Recent Development
Table 101. AstraZeneca Company Detail
Table 102. AstraZeneca Business Overview
Table 103. AstraZeneca Geographic Atrophy Product
Table 104. AstraZeneca Revenue in Geographic Atrophy Business (2019-2024) & (US$ Million)
Table 105. AstraZeneca Recent Development
Table 106. Lineage Cell Therapeutics Company Detail
Table 107. Lineage Cell Therapeutics Business Overview
Table 108. Lineage Cell Therapeutics Geographic Atrophy Product
Table 109. Lineage Cell Therapeutics Revenue in Geographic Atrophy Business (2019-2024) & (US$ Million)
Table 110. Lineage Cell Therapeutics Recent Development
Table 111. Allergan Company Detail
Table 112. Allergan Business Overview
Table 113. Allergan Geographic Atrophy Product
Table 114. Allergan Revenue in Geographic Atrophy Business (2019-2024) & (US$ Million)
Table 115. Allergan Recent Development
Table 116. Research Programs/Design for This Report
Table 117. Key Data Information from Secondary Sources
Table 118. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Geographic Atrophy Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Geographic Atrophy Market Share by Type: 2023 VS 2030
Figure 3. Above 60 Years Features
Figure 4. Above 75 Years Features
Figure 5. Global Geographic Atrophy Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 6. Global Geographic Atrophy Market Share by Application: 2023 VS 2030
Figure 7. Late-stage (Phase III) Case Studies
Figure 8. Phase II Case Studies
Figure 9. Phase I Case Studies
Figure 10. Pre-clinical stage Case Studies
Figure 11. Geographic Atrophy Report Years Considered
Figure 12. Global Geographic Atrophy Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 13. Global Geographic Atrophy Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 14. Global Geographic Atrophy Market Share by Region: 2023 VS 2030
Figure 15. Global Geographic Atrophy Market Share by Players in 2023
Figure 16. Global Top Geographic Atrophy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Geographic Atrophy as of 2023)
Figure 17. The Top 10 and 5 Players Market Share by Geographic Atrophy Revenue in 2023
Figure 18. North America Geographic Atrophy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 19. North America Geographic Atrophy Market Share by Country (2019-2030)
Figure 20. United States Geographic Atrophy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 21. Canada Geographic Atrophy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. Europe Geographic Atrophy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. Europe Geographic Atrophy Market Share by Country (2019-2030)
Figure 24. Germany Geographic Atrophy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. France Geographic Atrophy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. U.K. Geographic Atrophy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. Italy Geographic Atrophy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Russia Geographic Atrophy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Nordic Countries Geographic Atrophy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Asia-Pacific Geographic Atrophy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Asia-Pacific Geographic Atrophy Market Share by Region (2019-2030)
Figure 32. China Geographic Atrophy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Japan Geographic Atrophy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. South Korea Geographic Atrophy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. Southeast Asia Geographic Atrophy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. India Geographic Atrophy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Australia Geographic Atrophy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Latin America Geographic Atrophy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Latin America Geographic Atrophy Market Share by Country (2019-2030)
Figure 40. Mexico Geographic Atrophy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Brazil Geographic Atrophy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Middle East & Africa Geographic Atrophy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Middle East & Africa Geographic Atrophy Market Share by Country (2019-2030)
Figure 44. Turkey Geographic Atrophy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Saudi Arabia Geographic Atrophy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. Apellis Pharmaceuticals Revenue Growth Rate in Geographic Atrophy Business (2019-2024)
Figure 47. Iveric Bio Revenue Growth Rate in Geographic Atrophy Business (2019-2024)
Figure 48. Alkeus Pharmaceuticals Revenue Growth Rate in Geographic Atrophy Business (2019-2024)
Figure 49. Hemera Biosciences Revenue Growth Rate in Geographic Atrophy Business (2019-2024)
Figure 50. Allegro Ophthalmics Revenue Growth Rate in Geographic Atrophy Business (2019-2024)
Figure 51. Stealth BioTherapeutics Revenue Growth Rate in Geographic Atrophy Business (2019-2024)
Figure 52. Gyroscope Therapeutics Revenue Growth Rate in Geographic Atrophy Business (2019-2024)
Figure 53. Regenerative Patch Technologies Revenue Growth Rate in Geographic Atrophy Business (2019-2024)
Figure 54. Roche Revenue Growth Rate in Geographic Atrophy Business (2019-2024)
Figure 55. Gensight Biologics Revenue Growth Rate in Geographic Atrophy Business (2019-2024)
Figure 56. NGM Biopharmaceuticals Revenue Growth Rate in Geographic Atrophy Business (2019-2024)
Figure 57. AstraZeneca Revenue Growth Rate in Geographic Atrophy Business (2019-2024)
Figure 58. Lineage Cell Therapeutics Revenue Growth Rate in Geographic Atrophy Business (2019-2024)
Figure 59. Allergan Revenue Growth Rate in Geographic Atrophy Business (2019-2024)
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
